Earnings Summary

Vertex Pharmaceuticals Incorporated’s revenue jumped 9.34% since last year same period to $2517.7Mn in the Q4 2023. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated 1.38% jump in its revenue since last 3-months.

Vertex Pharmaceuticals Incorporated’s net profit jumped 18.31% since last year same period to $968.8Mn in the Q4 2023. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated -6.42% fall in its net profits since last 3-months.

Vertex Pharmaceuticals Incorporated’s net profit margin jumped 8.2% since last year same period to 38.48% in the Q4 2023. On a quarterly growth basis, Vertex Pharmaceuticals Incorporated has generated -7.69% fall in its net profit margins since last 3-months.

Vertex Pharmaceuticals Incorporated’s earning per share (EPS) estimates for the current quarter stand at 4.07 - a -0.73% fall from last quarter’s estimates.

Vertex Pharmaceuticals Incorporated’s earning per share (EPS) estimates for the current year stand at 4.07.

Vertex Pharmaceuticals Incorporated’s earning per share (EPS) jumped 11.7% since last year same period to 4.2 in the Q4 2023. This indicates that the Vertex Pharmaceuticals Incorporated has generated 11.7% annual rate of jump in its earning per share (EPS) in the last 4 quarters.